Future multi-institutional study of matched human tumor tissue (primary lung, solid parenchymal brain metastases, and LM), and genetically modifiable in vivo mouse models of LM, will allow us to further determine how and under what treatment pressure CEACAM6 promotes brain-trophic metastases. The gene discussed is CEACAM6; the disease is lymphangioma.